CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 28 filers reported holding CARDIOME PHARMA CORP in Q2 2017. The put-call ratio across all filers is 6.65 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $2,000 | 0.0% | 675 | -45.3% | 0.00% | – |
Q4 2017 | $2,000 | -50.0% | 1,233 | -34.7% | 0.00% | – |
Q3 2017 | $4,000 | -20.0% | 1,889 | +79.7% | 0.00% | – |
Q2 2017 | $5,000 | +66.7% | 1,051 | +23.4% | 0.00% | – |
Q1 2017 | $3,000 | -57.1% | 852 | -65.9% | 0.00% | – |
Q4 2016 | $7,000 | -85.4% | 2,497 | -84.0% | 0.00% | – |
Q3 2016 | $48,000 | -40.7% | 15,575 | -1.5% | 0.00% | – |
Q2 2016 | $81,000 | +26.6% | 15,816 | +1.5% | 0.00% | – |
Q1 2016 | $64,000 | -55.2% | 15,575 | -11.4% | 0.00% | – |
Q4 2015 | $143,000 | +320.6% | 17,575 | +327.8% | 0.00% | – |
Q3 2015 | $34,000 | -8.1% | 4,108 | +4.7% | 0.00% | – |
Q2 2015 | $37,000 | -28.8% | 3,922 | -29.7% | 0.00% | – |
Q1 2015 | $52,000 | -38.1% | 5,582 | -38.1% | 0.00% | – |
Q4 2014 | $84,000 | -78.5% | 9,025 | -79.4% | 0.00% | – |
Q3 2014 | $391,000 | +475.0% | 43,809 | +405.2% | 0.00% | – |
Q2 2014 | $68,000 | 0.0% | 8,672 | +0.2% | 0.00% | – |
Q1 2014 | $68,000 | +172.0% | 8,655 | +112.8% | 0.00% | – |
Q4 2013 | $25,000 | +177.8% | 4,067 | +57.6% | 0.00% | – |
Q3 2013 | $9,000 | +80.0% | 2,581 | -5.9% | 0.00% | – |
Q2 2013 | $5,000 | – | 2,743 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 2,757,260 | $8,299,000 | 4.68% |
Tamarack Advisers, LP | 1,825,000 | $5,493,000 | 3.43% |
CLOUGH CAPITAL PARTNERS L P | 2,958,415 | $8,905,000 | 0.56% |
AlphaOne Investment Services, LLC | 550,712 | $1,653,000 | 0.42% |
Rock Springs Capital Management LP | 1,200,000 | $3,612,000 | 0.21% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 4,894,948 | $14,734,000 | 0.13% |
KNOTT DAVID M | 76,300 | $230,000 | 0.11% |
SABBY MANAGEMENT, LLC | 273,010 | $819,000 | 0.04% |
PUTNAM INVESTMENTS LLC | 3,438,484 | $10,315,000 | 0.02% |
ARDSLEY ADVISORY PARTNERS LP | 40,000 | $120,000 | 0.02% |